Circulating 25-Hydroxyvitamin D and Risk of Epithelial Ovarian Cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers
Open Access
- 18 June 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 172 (1) , 70-80
- https://doi.org/10.1093/aje/kwq118
Abstract
A role for vitamin D in ovarian cancer etiology is supported by ecologic studies of sunlight exposure, experimental mechanism studies, and some studies of dietary vitamin D intake and genetic polymorphisms in the vitamin D receptor. However, few studies have examined the association of circulating 25-hydroxyvitamin D (25(OH)D), an integrated measure of vitamin D status, with ovarian cancer risk. A nested case-control study was conducted among 7 prospective studies to evaluate the circulating 25(OH)D concentration in relation to epithelial ovarian cancer risk. Logistic regression models were used to estimate odds ratios and 95% confidence intervals among 516 cases and 770 matched controls. Compared with 25(OH)D concentrations of 50–2 (Pinteraction < 0.01). In conclusion, this large pooled analysis did not support an overall association between circulating 25(OH)D and ovarian cancer risk, except possibly among overweight women.Keywords
This publication has 45 references indexed in Scilit:
- Circulating 25-Hydroxyvitamin D and the Risk of Rarer Cancers: Design and Methods of the Cohort Consortium Vitamin D Pooling Project of Rarer CancersAmerican Journal of Epidemiology, 2010
- Polymorphisms in the Vitamin D Receptor and Risk of Ovarian Cancer in Four StudiesCancer Research, 2009
- Circulating Vitamin D and Risk of Epithelial Ovarian CancerJournal of Oncology, 2009
- Serum 25-hydroxyvitamin D status of the US population: 1988–1994 compared with 2000–2004The American Journal of Clinical Nutrition, 2008
- Height, Body Mass Index, and Ovarian Cancer: A Pooled Analysis of 12 Cohort StudiesCancer Epidemiology, Biomarkers & Prevention, 2008
- Vitamin D receptor polymorphisms and risk of epithelial ovarian cancerCancer Letters, 2008
- The epidemiology of vitamin D and cancer incidence and mortality: A review (United States)Cancer Causes & Control, 2005
- Pathology and classification of ovarian tumorsCancer, 2003
- Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case-control studyOccupational and Environmental Medicine, 2002
- Inhibition of breast and ovarian carcinoma cell growth by 1,25-dihydroxyvitamin D3 combined with retinoic acid or dexamethasoneAnti-Cancer Drugs, 1995